Literature DB >> 24351760

Survey of laboratory animal technicians in the United States for Coxiella burnetii antibodies and exploration of risk factors for exposure.

Ellen A Spotts Whitney1, Robert F Massung2, Gilbert J Kersh2, Kelly A Fitzpatrick2, Deborah M Mook3, Douglas K Taylor3, Michael J Huerkamp3, Jessica C Vakili4, Patrick J Sullivan5, Ruth L Berkelman6.   

Abstract

Little is known about the prevalence of zoonotic infections among laboratory animal care technicians (LAT). Q fever, a disease caused by Coxiella burnetii, is a known occupational hazard for persons caring for livestock. We sought to determine the seroprevalence of C. burnetii antibodies among LAT and to identify risk factors associated with C. burnetii seropositivity. A survey was administered and serum samples collected from a convenience sample of 97 LAT. Samples were screened by using a Q fever IgG ELISA. Immunofluorescent antibody assays for phase I and phase II IgG were used to confirm the status of samples that were positive or equivocal by ELISA; positive samples were titered to endpoint. Antibodies against C. burnetii were detected in 6 (6%) of the 97 respondents. In our sample of LAT, seropositivity to C. burnetii was therefore twice as high in LAT as compared with the general population. Age, sex, and working with sheep regularly were not associated with seropositivity. Risk factors associated with seropositivity included breeding cattle within respondent's research facility, any current job contact with waste from beef cattle or goats, and exposure to animal waste during previous jobs or outside of current job duties. Only 15% of responding LAT reported being aware that sheep, goats, and cattle can transmit Q fever. Research facilities that use cattle or goats should evaluate their waste-management practices and educational programs in light of these findings. Additional efforts are needed to increase awareness among LAT regarding Q fever and heightened risk of exposure to infectious materials. Physicians should consider the risk of infection with C. burnetii when treating LAT with potential occupational exposures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24351760      PMCID: PMC3838606     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  39 in total

1.  A quantifiable alternative to double data entry.

Authors:  D W King; R Lashley
Journal:  Control Clin Trials       Date:  2000-04

2.  Risks factors and prevention of Q fever endocarditis.

Authors:  F Fenollar; P E Fournier; M P Carrieri; G Habib; T Messana; D Raoult
Journal:  Clin Infect Dis       Date:  2001-06-25       Impact factor: 9.079

3.  Summary of Notifiable Diseases - United States, 2011.

Authors:  Deborah A Adams; Kathleen M Gallagher; Ruth Ann Jajosky; Jeffrey Kriseman; Pearl Sharp; Willie J Anderson; Aaron E Aranas; Michelle Mayes; Michael S Wodajo; Diana H Onweh; John P Abellera
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-07-05       Impact factor: 17.586

4.  Long-Term immune responses to Coxiella burnetii after vaccination.

Authors:  Gilbert J Kersh; Kelly A Fitzpatrick; Joshua S Self; Brad J Biggerstaff; Robert F Massung
Journal:  Clin Vaccine Immunol       Date:  2012-11-28

5.  Q fever during pregnancy: diagnosis, treatment, and follow-up.

Authors:  Didier Raoult; Florence Fenollar; Andreas Stein
Journal:  Arch Intern Med       Date:  2002-03-25

6.  Q fever and pregnancy: disease, prevention, and strain specificity.

Authors:  E Angelakis; M Million; F D'Amato; L Rouli; H Richet; A Stein; J-M Rolain; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-28       Impact factor: 3.267

7.  Prevalence of Coxiella burnetii in ticks after a large outbreak of Q fever.

Authors:  H Sprong; E Tijsse-Klasen; M Langelaar; A De Bruin; M Fonville; F Gassner; W Takken; S Van Wieren; A Nijhof; F Jongejan; C B M Maassen; E-J Scholte; J W Hovius; K Emil Hovius; E Spitalská; Y T Van Duynhoven
Journal:  Zoonoses Public Health       Date:  2011-06-28       Impact factor: 2.702

8.  Coxiella burnetii associated placental lesions and infection level in parturient cows.

Authors:  Mette S Hansen; Annie Rodolakis; Denis Cochonneau; Jens F Agger; Anna-Bodil Christoffersen; Tim K Jensen; Jørgen S Agerholm
Journal:  Vet J       Date:  2011-02-02       Impact factor: 2.688

9.  Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group.

Authors:  Alicia Anderson; Henk Bijlmer; Pierre-Edouard Fournier; Stephen Graves; Joshua Hartzell; Gilbert J Kersh; Gijs Limonard; Thomas J Marrie; Robert F Massung; Jennifer H McQuiston; William L Nicholson; Christopher D Paddock; Daniel J Sexton
Journal:  MMWR Recomm Rep       Date:  2013-03-29

10.  Time-course of antibody responses against Coxiella burnetii following acute Q fever.

Authors:  P F M Teunis; B Schimmer; D W Notermans; A C A P Leenders; P C Wever; M E E Kretzschmar; P M Schneeberger
Journal:  Epidemiol Infect       Date:  2012-04-04       Impact factor: 4.434

View more
  3 in total

1.  Seroprevalence and Risk Factors for Coxiella burnetii in Jordan.

Authors:  Mohammad M Obaidat; Lile Malania; Paata Imnadze; Amira A Roess; Alaa E Bani Salman; Ryan J Arner
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

2.  Ex vivo ovine model for teaching open laryngotracheal surgery.

Authors:  Ahmed M S Soliman; David C Ianacone; Glenn C Isaacson
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-06-28

Review 3.  Surgical Training on Ex Vivo Ovine Model in Otolaryngology Head and Neck Surgery: A Comprehensive Review.

Authors:  Matteo Fermi; Francesco Chiari; Francesco Mattioli; Marco Bonali; Giulia Molinari; Matteo Alicandri-Ciufelli; Lukas Anschuetz; Ignacio Javier Fernandez; Livio Presutti
Journal:  Int J Environ Res Public Health       Date:  2022-03-19       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.